Stereoselective interaction of pantoprazole with ABCG2. II. In vitro flux analysis

Drug Metabolism and Disposition

Volumn 40, Issue 5, 2012, Pages 1024-1031

  Wang, Lipeng ^a   Leggas, Markos ^a   Empey, Philip E ^b   McNamara, Patrick J ^a  

^a University of Kentucky   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; PANTOPRAZOLE;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG PENETRATION; DRUG TRANSPORT; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; STEREOCHEMISTRY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CELL MEMBRANE PERMEABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MASS SPECTROMETRY; MILK; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; NEOPLASM PROTEINS; RATS; STEREOISOMERISM; TRANSFECTION;

RATTUS;

EID: 84859889914     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.041616     Document Type: Article

References (22)

1. Balimane PV and Chong S (2005) A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay. Int J Pharm 301:80-88. (Pubitemid 41206593)
2. Balimane PV, Patel K, Marino A, and Chong S (2004) Utility of 96 well Caco-2 cell system for increased throughput of P-gp screening in drug discovery. Eur J Pharm Biopharm 58:99-105. (Pubitemid 38781010)
3. Breedveld P, Zelcer N, Pluim D, Sönmezer O, Tibben MM, Beijnen JH, Schinkel AH, van Tellingen O, Borst P, and Schellens JH (2004) Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions. Cancer Res 64:5804-5811. (Pubitemid 39095580)
4. Empey PE, Leggas M, and McNamara PJ (2006) PhIP transport in ABCG2 stably transfected MDCKII cells. American Association of Pharmaceutical Scientists Meeting; 2006 Nov 1; San Antonio, TX. AAPS PharmSci 8(S2), Abstract W5320.
5. Gerk PM, Kuhn RJ, Desai NS, and McNamara PJ (2001) Active transport of nitrofurantoin into human milk. Pharmacotherapy 21:669-675. (Pubitemid 32506482)
6. Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, et al. (2010) Membrane transporters in drug development. Nat Rev Drug Discov 9:215-236.
7. Jonker JW, Merino G, Musters S, van Herwaarden AE, Bolscher E, Wagenaar E, Mesman E, Dale TC, and Schinkel AH (2005) The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat Med 11:127-129. (Pubitemid 40321346)
8. Kalvass JC and Pollack GM (2007) Kinetic considerations for the quantitative assessment of efflux activity and inhibition: implications for understanding and predicting the effects of efflux inhibition. Pharm Res 24:265-276. (Pubitemid 46072186)
9. McNamara PJ, Meece JA, and Paxton E (1996) Active transport of cimetidine and ranitidine into the milk of Sprague Dawley rats. J Pharmacol Exp Ther 277:1615-1621. (Pubitemid 27167179)
10. Merino G, Alvarez AI, Pulido MM, Molina AJ, Schinkel AH, and Prieto JG (2006) Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion. Drug Metab Dispos 34:690-695.
11. Merino G, Jonker JW, Wagenaar E, Pulido MM, Molina AJ, Alvarez AI, and Schinkel AH (2005) Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2). Drug Metab Dispos 33:614-618. (Pubitemid 40593873)
12. Oo CY, Kuhn RJ, Desai N, and McNamara PJ (1995) Active transport of cimetidine into human milk. Clin Pharmacol Ther 58:548-555.
13. Oo CY, Paxton EW, and McNamara PJ (2001) Active transport of nitrofurantoin into rat milk. Adv Exp Med Biol 501:547-552. (Pubitemid 34102240)
14. Pan G, Giri N, and Elmquist WF (2007) Abcg2/Bcrp1 mediates the polarized transport of antiretroviral nucleosides abacavir and zidovudine. Drug Metab Dispos 35:1165-1173. (Pubitemid 46956438)
15. Plante L, Ferron GM, Unruh M, and Mayer PR (2004) Excretion of pantoprazole in human breast. J Reprod Med 49:825-827.
16. Sun H and Pang KS (2008) Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical study. Drug Metab Dispos 36:102-123.
17. Tanaka M, Ohkubo T, Otani K, Suzuki A, Kaneko S, Sugawara K, Ryokawa Y, and Ishizaki T (2001) Stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin. Clin Pharmacol Ther 69:108-113. (Pubitemid 32225410)
18. van Herwaarden AE, Wagenaar E, Merino G, Jonker JW, Rosing H, Beijnen JH, and Schinkel AH (2007) Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk. Mol Cell Biol 27:1247-1253. (Pubitemid 46239808)
19. Vlaming ML, Lagas JS, and Schinkel AH (2009) Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv Drug Deliv Rev 61:14-25.
20. Wang L, Leggas M, Goswami M, Empey PE, and McNamara PJ (2008) N-(4-[2-(1,2,3,4- Tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10- dihydro-5-methoxy-9-oxo-4- acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk. Drug Metab Dispos 36:2591-2596.
21. Wang L and McNamara PJ (2012) Stereoselective Interaction of Pantoprazole with ABCG2. I. Drug accumulation in rat milk. Drug Metab Dispos 40:1018-1023.
22. Xie Z, Zhang Y, Xu H, and Zhong D (2005) Pharmacokinetic differences between pantoprazole enantiomers in rats. Pharm Res 22:1678-1684. (Pubitemid 41355907)